Abstract
"... 2016 saw the first approval of an adalimumab biosimilar when the US FDA approved Amjevita (Amgen (R), CA, USA) on 23 September, approving it for ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
